Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04038359
Brief Title: A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Subjects With Indolent Non-Hodgkin Lymphoma. (TEMPO)

First Submitted : July 10, 2019
First Submitted that Met QC Criteria : July 26, 2019
First Posted : July 30, 2019

Last Update Submitted that Met QC Criteria : October 1, 2019
Last Update Posted : October 3, 2019